NEXENTIS TECHNOLOGIES INC. Operating Cash Flow
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Operating Cash Flow of -$1.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$539.00K.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.42M.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.50M.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$974.00K.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2025 was -$3.81M.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2024 was -$3.42M.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2023 was -$3.23M.
- NEXENTIS TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2022 was -$5.10M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$539.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.96M 10-Q · filed 2026-08-13 | -$3.46M derived: sum of 3 quarters · filed 2026-08-13 | -$4.43M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$1.42M 10-Q · filed 2026-05-14 | -$2.92M derived: sum of 2 quarters · filed 2026-05-14 | -$3.89M derived: sum of 3 quarters · filed 2026-05-14 | -$4.42M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.47M derived: sum of 2 quarters · filed 2026-03-31 | -$3.00M derived: sum of 3 quarters · filed 2026-08-13 | -$3.81M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$974.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.50M derived: sum of 2 quarters · filed 2026-08-13 | -$2.31M 10-Q · filed 2025-11-13 | -$2.80M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.34M 10-Q · filed 2026-08-13 | -$1.83M derived: sum of 3 quarters · filed 2026-08-13 | -$2.72M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$809.00K 10-Q · filed 2026-05-14 | -$1.30M derived: sum of 2 quarters · filed 2026-05-14 | -$2.19M derived: sum of 3 quarters · filed 2026-05-14 | -$3.22M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.38M derived: sum of 2 quarters · filed 2026-03-31 | -$2.41M derived: sum of 3 quarters · filed 2026-03-31 | -$3.42M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.92M derived: sum of 2 quarters · filed 2025-11-13 | -$2.93M 10-Q · filed 2025-11-13 | -$2.93M 10-Q · filed 2024-11-14 | -$3.90M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.04M 10-Q · filed 2025-08-14 | -$2.04M 10-Q · filed 2024-08-14 | -$3.01M derived: sum of 3 quarters · filed 2025-08-14 | -$3.64M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$1.01M 10-Q · filed 2025-05-15 | -$1.01M 10-Q · filed 2024-05-15 | -$1.98M derived: sum of 2 quarters · filed 2025-05-15 | -$2.61M derived: sum of 3 quarters · filed 2025-05-15 | -$3.14M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$975.13K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.60M derived: sum of 2 quarters · filed 2025-03-31 | -$2.13M derived: sum of 3 quarters · filed 2025-03-31 | -$3.23M 10-K · filed 2025-03-31 | -$3.23M 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$624.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.15M derived: sum of 2 quarters · filed 2024-11-14 | -$2.26M 10-Q · filed 2024-11-14 | -$3.23M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$528.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.63M 10-Q · filed 2024-08-14 | -$2.60M derived: sum of 3 quarters · filed 2024-08-14 | -$4.38M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$1.11M 10-Q · filed 2024-05-15 | -$2.08M derived: sum of 2 quarters · filed 2024-05-15 | -$3.85M derived: sum of 3 quarters · filed 2024-05-15 | -$5.12M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$970.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$2.74M derived: sum of 2 quarters · filed 2024-04-01 | -$4.01M derived: sum of 3 quarters · filed 2024-04-01 | -$5.10M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$3.04M derived: sum of 2 quarters · filed 2023-11-14 | -$4.13M 10-Q · filed 2023-11-14 | -$5.05M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.36M 10-Q · filed 2023-08-14 | -$3.28M derived: sum of 3 quarters · filed 2023-08-14 | -$4.75M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$1.09M 10-Q · filed 2023-05-15 | -$1.09M 10-Q · filed 2022-05-16 | -$2.01M derived: sum of 2 quarters · filed 2023-05-15 | -$3.48M derived: sum of 3 quarters · filed 2023-05-15 | -$5.11M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$923.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$2.40M derived: sum of 2 quarters · filed 2023-03-27 | -$4.03M derived: sum of 3 quarters · filed 2023-03-27 | -$4.11M 10-K · filed 2023-03-27 | -$4.10M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.11M derived: sum of 2 quarters · filed 2022-11-14 | -$3.19M 10-Q · filed 2022-11-14 | -$3.17M 10-Q · filed 2021-11-15 | -$3.37M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.72M 10-Q · filed 2022-08-15 | -$1.71M 10-Q · filed 2021-08-16 | -$1.90M derived: sum of 3 quarters · filed 2022-08-15 | -$2.05M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | -$84.55K 10-Q · filed 2022-05-16 | -$81.37K 10-Q · filed 2021-05-18 | -$263.89K derived: sum of 2 quarters · filed 2022-05-16 | -$414.29K derived: sum of 3 quarters · filed 2022-05-16 | -$649.65K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$179.34K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$329.74K derived: sum of 2 quarters · filed 2022-03-31 | -$565.10K derived: sum of 3 quarters · filed 2022-03-31 | -$798.74K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$150.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$385.76K derived: sum of 2 quarters · filed 2021-11-15 | -$619.40K 10-Q · filed 2021-11-15 | -$984.39K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$235.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$469.00K 10-Q · filed 2021-08-16 | -$833.99K derived: sum of 3 quarters · filed 2021-08-16 | -$1.12M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$233.64K 10-Q · filed 2021-05-18 | -$598.63K derived: sum of 2 quarters · filed 2021-05-18 | -$883.73K derived: sum of 3 quarters · filed 2021-05-18 | -$1.15M derived: sum of 4 quarters · filed 2021-05-18 | ||||
| 2019-12-31 | -$364.99K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$650.09K derived: sum of 2 quarters · filed 2021-03-29 | -$917.88K derived: sum of 3 quarters · filed 2021-03-29 | -$1.24M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$285.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$552.89K derived: sum of 2 quarters · filed 2020-11-12 | -$879.78K 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | -$267.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$594.68K 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | -$326.89K 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | -$506.50K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |